Looking to sell Injective stock or options?
Injective is the developer of a decentralized exchange protocol for derivatives, aimed at establishing a free and inclusive financial system. Their protocol leverages cryptographic research on verifiable delay functions to remove front-running and facilitate trustless liquidity sharing. This assists clients in tackling key security vulnerabilities and scalability issues inherent in decentralized exchanges.
BoxOne Ventures, Pnyx Ventures, GravityX Capital, Ellipti, Binance, QCP Group, Pantera Capital, Cadenza Capital, K42, Innovating Capital, ZBS Capital, AU21 Capital, Chorus Ventures, QCP Soteria, Arche Fund, Figment Capital, Krypital Group, BlockTower Capital, Axia8 Ventures, ODIG, Black Mamba Ventures, Drops Ventures, West Labs, StartX (US), Bitscale Capital.